Fecal Microbiota Signatures Are Associated with Response to Ustekinumab Therapy among Crohn’s Disease Patients

The fecal microbiota is a rich source of biomarkers that have previously been shown to be predictive of numerous disease states. Less well studied is the effect of immunomodulatory therapy on the microbiota and its role in response to therapy. This study explored associations between the fecal micro...

Descripción completa

Detalles Bibliográficos
Autores principales: Doherty, Matthew K., Ding, Tao, Koumpouras, Charlie, Telesco, Shannon E., Monast, Calixte, Das, Anuk, Brodmerkel, Carrie, Schloss, Patrick D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850325/
https://www.ncbi.nlm.nih.gov/pubmed/29535202
http://dx.doi.org/10.1128/mBio.02120-17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850325/
https://www.ncbi.nlm.nih.gov/pubmed/29535202
http://dx.doi.org/10.1128/mBio.02120-17

Ejemplares similares